/ Lupin Launches Generic Wellbutrin XL Tablets In The US ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Thursday, 15 June 2017

Lupin Limited has launched the generic Wellbutrin XL tablets in the United States, the company informed the bourses.

Wellbutrin XL is used to treat major depressive disorder in adults and has US sales of $758 mn, till May 2017, as per data available by IMS.

The stock on the NSE was trading at Rs 1,184 per share higher by Rs 3 per share or 0.3%. The stock has delivered negative returns of 19% in a period of one year and has underperformed the BSE Sensex and BSE Healthcare indices over the same time span.

Lupin Limited is the seventh-largest company by market capitalization; and the 10th largest generic pharmaceutical company by revenue, globally. The company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.

or Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔